MiMedx Challenges FDA Classification Of Wound Care Powder
By Kelcey Caulder · March 20, 2025, 8:02 PM EDT
Biomedical company MiMedx Group urged a Georgia federal judge on Thursday to overturn the U.S. Food and Drug Administration's classification of a wound care treatment as a biological product, arguing the...
To view the full article, register now.